Abstract
In this issue of Blood, Michael et al report that microparticles produced by platelets can infiltrate tumors outside the vasculature. Microparticles transfer their microRNA cargo to tumor cells, which triggers apoptosis and thereby reduces tumor growth.1 This study highlights a novel role of platelets, via their microparticles, in tumor pathogenesis.
Cite
CITATION STYLE
APA
Boilard, E. (2017, August 3). Platelet-derived nanomedicine targets cancer. Blood. American Society of Hematology. https://doi.org/10.1182/blood-2017-05-786327
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.
Already have an account? Sign in
Sign up for free